A study of SGLT2 inhibitors on levels of plasma atherogenesis biomarkers in diabetes
From our study, we observed that SGLT2 inhibitor shows significant improvement in glycemic profile in addition to lipid profile. SGLT2 inhibitor lowered atherogenic indices.
Authors
- P Balamanikandan
- Naveenkumar Nallathambi (ORCID: https://orcid.org/0000-0002-5926-8955)
- C Adithyan
- V Pratheep
- Yogesh Subramanian (ORCID: https://orcid.org/0009-0005-2321-2123)
Institutions
- Madras Medical College (IN)
Publication Details
- Journal
- Journal of Family Medicine and Primary Care
- Published
- 2024-11-01
- DOI
- https://doi.org/10.4103/jfmpc.jfmpc_908_24
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72